# OnCo record paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026" ;
  schema:name "Immunotherapy access for small cell lung cancer in Lebanon after subsidies were withdrawn"@en ;
  schema:description "After Lebanon withdrew public subsidies for immunotherapy drugs in October 2022, three quarters of patients with extensive small cell lung cancer at one Beirut hospital did not receive the recommended treatment, and access depended on how they paid."@en ;
  schema:url <https://onco.cc/key-papers/paper-el-assaad-ici-subsidy-sclc-lebanon-jcogo-2026/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/go-25-00564>, <https://pubmed.ncbi.nlm.nih.gov/41604600/> ;
  schema:sameAs <https://doi.org/10.1200/go-25-00564> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "El Assaad N, Slim M, Yeretzian J, et al." ;
  onco:cancers <https://onco.cc/cancers/extensive-stage-sclc/> .
